As of April 16, 2025, Enliven Therapeutics (ELVN) has a market cap of $0.84 billion USD. According to our data, Enliven Therapeutics is ranked No.5281 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.84 B |
-24.00%
|
Dec 31, 2024 | $1.10 B |
62.57%
|
Dec 29, 2023 | $0.68 B |
238.39%
|
Dec 30, 2022 | $0.20 B |
81.78%
|
Dec 31, 2021 | $0.11 B |
-89.80%
|
Dec 31, 2020 | $1.08 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Amgen
AMGN
|
$158.77 B |
0.132 B
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
![]() USA
|
![]() Biogen
BIIB
|
$17.12 B |
0.000 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$128.67 B |
-0.003 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.51 B |
-0.000 M
|
![]() USA
|
![]() Alnylam Pharmaceuticals
ALNY
|
$29.89 B |
-0.001 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.28 B |
-0.000 M
|
![]() USA
|
![]() Incyte
INCY
|
$11.31 B |
0.000 M
|
![]() USA
|
![]() Illumina
ILMN
|
$11.80 B |
-0.000 M
|
![]() USA
|
![]() Exelixis
EXEL
|
$10.23 B |
0.000 M
|
![]() USA
|
![]() Blueprint Medicines
BPMC
|
$5.21 B |
0.000 M
|
![]() USA
|
![]() BeiGene
BGNE
|
$20.21 B |
-1.816 B
|
![]() China
|
Market Cap | = | ELVN Stock Price | * | ELVN Shares Outstanding |
= | $17.05 | * | 49.00 M | |
= | $0.84 B |